Estimated readout windows: registry primary-completion date + 6-12 weeks. Windows already open are shown from "Now". Drug names link to ClinicalTrials.gov.
Partnerships Filaxis (commercial partner, Latin America — Ampligen in Argentina); AstraZeneca Imfinzi (durvalumab) used in combination in investigator-initiated DURIPANC study at Erasmus MC (no agreement terms disclosed)
Indications
Metastatic pancreatic cancer (with Imfinzi/durvalumab, post-FOLFIRINOX)(Phase 2)
Locally advanced pancreatic cancer (AMP-270)(Phase 2)
ME/CFS and post-COVID fatigue(Phase 2)
Advanced recurrent ovarian cancer(Phase 2)
Influenza vaccine adjuvant (with FluMist; includes avian influenza)(Stage not disclosed)
Catalysts
— later in 2026
Status note Company's stated focus is Ampligen in late-stage pancreatic cancer following its pancreatic-cancer Early Access Program; anticipated Phase 3 design work under Mar 2026 agreement with PPD clinical research (Thermo Fisher), trial not yet initiated. AMP-518 (post-COVID conditions) completed 2023; close-out finished 2025; final results posted to ClinicalTrials.gov Jan 2025. Phase 1 portion of DURIPANC led to ongoing Phase 2 portion; all subjects enrolled and dosed as of Jun 30, 2026.
Alferon N Injection
Approved · Active
Aliases Interferon alfa
Target Interferon alfa receptor (IFNAR)
Indications
Condylomata acuminata (genital warts)(Approved)
Status note Approved commercial product; commercial sales halted due to lack of finished goods inventory per this filing.
Per-asset detail extracted from the 10-Q filed 2026-08-07. Fields the filing does not state are marked "not disclosed" rather than filled from other sources.
Sponsor-matched active trials from ClinicalTrials.gov (0 as sponsor, 4 as collaborator); "Sponsor" = company is the lead sponsor, "Collaborator" = company is a collaborator. The BP column flags big-pharma involvement as lead sponsor or collaborator (excluding the company itself). The Mgmt guide column shows what management guided for readout timing when a guided program matches the trial (hover for the quote, click for the source). Trial listings are not a company pipeline slide.